{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T05:41:11Z","timestamp":1776490871655,"version":"3.51.2"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MRC-RFA-UFSP-01-2013"],"award-info":[{"award-number":["MRC-RFA-UFSP-01-2013"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.schres.2018.02.050","type":"journal-article","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T00:52:46Z","timestamp":1520297566000},"page":"90-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Effects of cannabis use on body mass, fasting glucose and lipids during the first 12\u202fmonths of treatment in schizophrenia spectrum disorders"],"prefix":"10.1016","volume":"199","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-8599","authenticated-orcid":false,"given":"F.","family":"Scheffler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Kilian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Chiliza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Asmal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Phahladira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"du Plessis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Kidd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Di Forti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Seedat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Emsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2018.02.050_bb0005","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.schres.2018.02.050_bb0010","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2165\/00023210-200822070-00002","article-title":"Antipsychotic-induced weight gain in chronic and first-episode psychotic disorders: a systematic critical reappraisal","volume":"22","author":"Alvarez-Jimenez","year":"2008","journal-title":"CNS Drugs"},{"key":"10.1016\/j.schres.2018.02.050_bb0015","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"1994"},{"key":"10.1016\/j.schres.2018.02.050_bb0020","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0033291798008186","article-title":"The unhealthy lifestyle of people with schizophrenia","volume":"29","author":"Brown","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2018.02.050_bb0025","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1177\/0269881116631652","article-title":"Cannabis use in people with severe mental illness: the association with physical and mental health\u2013a cohort study. A pharmacotherapy monitoring and outcome survey study","volume":"30","author":"Bruins","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.02.050_bb0030","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.eurpsy.2014.11.013","article-title":"Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12\u202fmonths with a first-generation antipsychotic","volume":"30","author":"Chiliza","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.schres.2018.02.050_bb0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajcn\/87.4.801","article-title":"Consequences of smoking for body weight, body fat distribution, and insulin resistance","volume":"87","author":"Chiolero","year":"2008","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.schres.2018.02.050_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144270","article-title":"Prevention of diet-induced obesity effects on body weight and gut microbiota in mice treated chronically with Delta9-tetrahydrocannabinol","volume":"10","author":"Cluny","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.schres.2018.02.050_bb0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","article-title":"Antipsychotic drugs and obesity","volume":"17","author":"Correll","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.schres.2018.02.050_bb0050","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12991-017-0133-7","article-title":"Cardiometabolic comorbidities, readmission, and costs in schizophrenia and bipolar disorder: a real-world analysis","volume":"16","author":"Correll","year":"2017","journal-title":"Ann. General Psychiatry"},{"key":"10.1016\/j.schres.2018.02.050_bb0055","series-title":"Encyclopedia of Psychopharmacology","first-page":"538","article-title":"Flupenthixol","author":"de Wit","year":"2010"},{"key":"10.1016\/j.schres.2018.02.050_bb0060","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.biopsych.2012.06.020","article-title":"Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users","volume":"72","author":"Di Forti","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2018.02.050_bb0065","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pbb.2015.04.018","article-title":"Cigarette smoking may modify the association between cannabis use and adiposity in males","volume":"135","author":"Dube","year":"2015","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2018.02.050_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000342839","article-title":"Alcohol consumption patterns and body weight","volume":"62","author":"Dumesnil","year":"2013","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.schres.2018.02.050_bb0075","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.1984.03350140051025","article-title":"Detecting alcoholism. The CAGE questionnaire","volume":"252","author":"Ewing","year":"1984","journal-title":"JAMA"},{"key":"10.1016\/j.schres.2018.02.050_bb0080","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.amepre.2009.10.038","article-title":"Overweight, obesity, youth, and health-risk behaviors","volume":"38","author":"Farhat","year":"2010","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.schres.2018.02.050_bb0085","first-page":"62","article-title":"Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs","volume":"3","author":"Gohlke","year":"2012","journal-title":"Front. Psych."},{"key":"10.1016\/j.schres.2018.02.050_bb0090","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1192\/bjp.187.4.306","article-title":"Cannabis use and misuse prevalence among people with psychosis","volume":"187","author":"Green","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.02.050_bb0095","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1177\/0004867414553950","article-title":"Inadequate fruit and vegetable intake in people with psychosis","volume":"48","author":"Hahn","year":"2014","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2018.02.050_bb0100","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3109\/00952990.2010.500438","article-title":"Cannabis use and obesity and young adults","volume":"36","author":"Hayatbakhsh","year":"2010","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.schres.2018.02.050_bb0105","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1177\/0269881113482532","article-title":"Amphetamine, past and present\u2013a pharmacological and clinical perspective","volume":"27","author":"Heal","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2018.02.050_bb0110","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2018.02.050_bb0115","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.addbeh.2013.06.024","article-title":"Association between adolescent substance use and obesity in young adulthood: a group-based dual trajectory analysis","volume":"38","author":"Huang","year":"2013","journal-title":"Addict. Behav."},{"key":"10.1016\/j.schres.2018.02.050_bb0120","article-title":"Association between use of cannabis in adolescence and weight change into midlife","volume":"12","author":"Jin","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.schres.2018.02.050_bb0125","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jadohealth.2017.01.006","article-title":"Cannabis use, polysubstance use, and psychosis spectrum symptoms in a community-based sample of U.S. youth","volume":"60","author":"Jones","year":"2017","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.schres.2018.02.050_bb0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.02.050_bb0135","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/09540260902782810","article-title":"Cannabinoids and appetite: food craving and food pleasure 208","volume":"21","author":"Kirkham","year":"2009","journal-title":"Int. Rev. Psychiatry"},{"key":"10.1016\/j.schres.2018.02.050_bb0140","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/aje\/kwr200","article-title":"Obesity and cannabis use: results from 2 representative national surveys","volume":"174","author":"Le Strat","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.schres.2018.02.050_bb0145","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.schres.2018.02.050_bb0150","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.phymed.2012.02.001","article-title":"Cannabis exposure associated with weight reduction and beta-cell protection in an obese rat model","volume":"19","author":"Levendal","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.schres.2018.02.050_bb0155","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.schres.2016.08.014","article-title":"Cannabis and a lower BMI in psychosis: what is the role of AKT1?","volume":"176","author":"Liemburg","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2018.02.050_bb0160","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1016\/j.ijcard.2013.03.150","article-title":"Derivation and validation of a waist circumference optimal cutoff for diagnosing metabolic syndrome in a South African mixed ancestry population","volume":"168","author":"Matsha","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.schres.2018.02.050_bb0165","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/wps.20341","article-title":"Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis","volume":"15","author":"Murray","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/j.schres.2018.02.050_bb0170","series-title":"National Academies of Sciences, Engineering, and Medicine, Health and Medicine Division, Board on Population Health and Public Health Practice, Committee on the Health Effects of Marijuana: An Evidence Review and Research Agenda","article-title":"E.a.M. The Health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research","author":"National Academies of Science","year":"2017"},{"key":"10.1016\/j.schres.2018.02.050_bb0175","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/oby.20973","article-title":"Cannabis use in relation to obesity and insulin resistance in the Inuit population","volume":"23","author":"Ngueta","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.schres.2018.02.050_bb0180","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.amjmed.2013.03.002","article-title":"The impact of marijuana use on glucose, insulin, and insulin resistance among US adults","volume":"126","author":"Penner","year":"2013","journal-title":"Am. J. Med."},{"key":"10.1016\/j.schres.2018.02.050_bb0185","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjcard.2006.03.024","article-title":"Marijuana use, diet, body mass index, and cardiovascular risk factors (from the CARDIA study)","volume":"98","author":"Rodondi","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.schres.2018.02.050_bb0190","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1017\/S1355617716000278","article-title":"Decision-making does not moderate the association between cannabis use and body mass index among adolescent cannabis users","volume":"22","author":"Ross","year":"2016","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.schres.2018.02.050_bb0195","first-page":"50","article-title":"Marijuana and body weight","volume":"11","author":"Sansone","year":"2014","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.schres.2018.02.050_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009777","article-title":"Flupenthixol versus placebo for schizophrenia","volume":"11","author":"Shen","year":"2012","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.schres.2018.02.050_bb0205","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1079\/PHN2000114","article-title":"Dietary intake and nutritional status of US adult marijuana users: results from the third National Health and nutrition examination survey","volume":"4","author":"Smit","year":"2001","journal-title":"Public Health Nutr."},{"key":"10.1016\/j.schres.2018.02.050_bb0210","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/oxfordjournals.schbul.a007013","article-title":"Nutritional assessment of patients with schizophrenia: a preliminary study","volume":"29","author":"Strassnig","year":"2003","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2018.02.050_bb0215","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/sj.bjp.0707133","article-title":"Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro","volume":"150","author":"Thomas","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.schres.2018.02.050_bb0220","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.annepidem.2015.01.013","article-title":"Estimating the association between metabolic risk factors and marijuana use in U.S. adults using data from the continuous National Health and Nutrition Examination Survey","volume":"25","author":"Thompson","year":"2015","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.schres.2018.02.050_bb0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.beem.2008.10.002","article-title":"The role of the endocannabinoid system in lipogenesis and fatty acid metabolism","volume":"23","author":"Vettor","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.schres.2018.02.050_bb0230","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.amjmed.2015.10.019","article-title":"Metabolic syndrome among marijuana users in the United States: an analysis of national health and nutrition examination survey data","volume":"129","author":"Vidot","year":"2016","journal-title":"Am. J. Med."},{"key":"10.1016\/j.schres.2018.02.050_bb0235","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1017\/S0033291715002883","article-title":"Metabolic syndrome in people with a psychotic illness: is cannabis protective?","volume":"46","author":"Waterreus","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2018.02.050_bb0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.drugpo.2013.10.007","article-title":"The impact of methamphetamine (\"tik\") on a peri-urban community in cape town, South Africa","volume":"25","author":"Watt","year":"2014","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.schres.2018.02.050_bb0245","series-title":"Report of a WHO\/IDF Consultation","article-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia","author":"World Health Organisation","year":"2006"},{"key":"10.1016\/j.schres.2018.02.050_bb0250","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/j.dsx.2016.03.001","article-title":"A cross-sectional analysis of the association between marijuana and cigarette smoking with metabolic syndrome among adults in the United States","volume":"10","author":"Yankey","year":"2016","journal-title":"Diabetes Metab. Syndr."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418301282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996418301282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T21:44:09Z","timestamp":1568929449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996418301282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":50,"alternative-id":["S0920996418301282"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2018.02.050","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of cannabis use on body mass, fasting glucose and lipids during the first 12\u202fmonths of treatment in schizophrenia spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2018.02.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}